Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd VPTDF


Primary Symbol: V.VPT

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Introducing Ventripoint 4.0! 🚀 Dr. Adams is a visionary 👏
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12)
•••
Comment by jopatcloon Nov 13, 2024 2:26pm
46 Views
Post# 36310833

RE:Introducing Ventripoint 4.0! 🚀 Dr. Adams is a visionary 👏

RE:Introducing Ventripoint 4.0! 🚀 Dr. Adams is a visionary 👏
jopatclo wrote: Bravo  Now 4.0 Europe & Canada
Introducing Ventripoint 4.0! Ventripoint is a groundbreaking cardiac imaging tool that converts echo images into accurate volumes and ejection fractions for all four heart chambers, delivering results with the accuracy of cardiac MRI.

With its new capabilities, Ventripoint 4.0 provides additional insights, including:
3D Tensors: Visualise the direction and magnitude of surface changes.
4D Motion: Simulate a dynamic heart model across the cardiac cycle.
3D Global Strain: Assess longitudinal, circumferential, and total surface area changes.
3D Heat Map: Visualise surface area changes in a new heat map view.
3D Segmentation: Access a detailed polar map for surface area change analysis.
Ventripoint Diagnostics Ltd. CardiacImaging Innovation
 
 


@cardinal his entire focus every day is Ventripoint. Look for key material news right away
 
8
 
@cardinal lol--come on early. buy a few...have a great day...
 
6
 
@marcge81 @cardinal what timeframe is " right away "?
 
2
 
@napoca @marcge81 i don't think that someone could give you a timeframe for that, but from what I'm aware they are planning a company update
 
8
 
@yudi  Thank you @cardinal Look for key material news right away & @napoca they are planning a company update.
very positive wins at this point CardioLogic Ltd Introducing Ventripoint 4.0! Ventripoint is a groundbreaking cardiac imaging tool that converts echo images into accurate volumes and ejection fractions for all four heart chambers, delivering results with the accuracy of cardiac MRI. With its new capabilities, Ventripoint 4.0 provides additional insights, including: 3D Tensors: Visualise the direction and magnitude of surface changes. 4D Motion: Simulate a dynamic heart model across the cardiac cycle. 3D Global Strain: Assess longitudinal, circumferential, and total surface area changes. 3D Heat Map: Visualise surface area changes in a new heat map view. 3D Segmentation: Access a detailed polar map for surface area change analysis. Now That V4.0 Europe V4.0 ok & Canada The BEST automation and analysis of the PLANET GEN3EHO https://ascendcv.com/ (Ventripoint - The integration of Gen3Echo with Ventripoint’s innovative application of AI to echocardiography provides tremendous value to pediatric and adult echocardiographers in caring for their most complex patients.) I think they know more about the Ventripoint tech than the whiners on this board. Something could happen anytime real fast! FDA 4.0 It will happen, but not in a way we originally hoped. No investor is happy with the current outcome. You either wait or move on. Dr. Adams is a visionary with Ventripoint FDA V4.0 and Sales at any time now Insiders know! #vpt,

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities